Meissa Vaccines has a total of 12 patents globally, out of which no patents have been granted. Of these 12 patents, more than 91% patents are active. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Meissa Vaccines.
Meissa Vaccines was founded in the year 2014. The Company operates as a pharmaceutical development company. The Company focuses on the in-licensing and advancement of vaccines for respiratory syncytial virus and rhinovirus. Company offers vaccines that reduces the burden of acute lower respiratory tract disease, cold, and asthma.
Do read about some of the most popular patents of Meissa Vaccines which have been covered by us in this article and also you can find Meissa Vaccines patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Meissa Vaccines patent portfolio.
How many patents does Meissa Vaccines have?
Meissa Vaccines has a total of 12 patents globally. These patents belong to 2 unique patent families. Out of 12 patents, 11 patents are active.
How Many Patents did Meissa Vaccines File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Meissa Vaccines Applications Filed | Meissa Vaccines Patents Granted |
| 2023 | 1 | – |
| 2022 | 2 | – |
| 2021 | 9 | – |
How many Meissa Vaccines patents are Alive/Dead?
How Many Patents did Meissa Vaccines File in Different Countries?
Countries in which Meissa Vaccines Filed Patents
| Country | Patents |
| Taiwan | 1 |
| Japan | 1 |
| Argentina | 1 |
| Brazil | 1 |
| Mexico | 1 |
| Canada | 1 |
| Australia | 1 |
| United States Of America | 1 |
| Europe | 1 |
| Hong Kong (S.A.R.) | 1 |
Where are Research Centres of Meissa Vaccines Patents Located?
The Research Centre for all the Meissa Vaccines patents is the United States of America.
List of Meissa Vaccines Patents
| Meissa Vaccines Patents | Title |
| US20230248815A1 | Chimeric Rsv And Coronavirus Proteins, Immunogenic Compositions, And Methods Of Use |
| EP4168045A1 | Chimeric Rsv And Coronavirus Proteins, Immunogenic Compositions, And Methods Of Use |
| HK40091689A | Chimeric Rsv And Coronavirus Proteins, Immunogenic Compositions, And Methods Of Use |
| WO2023092100A3 | Methods Of Administering Chimeric Vaccines |
| JP2023530445A | Chimeric Rsv And Coronavirus Proteins, Immunogenic Compositions And Methods Of Use |
| MX2022016502A | Rsv And Coronavirus Chimeric Proteins, Immunogenic Compositions And Methods Of Use |
| BR112022025647A2 | Rsv And Coronavirus Chimeric Proteins, Immunogenic Compositions And Methods Of Use |
| AU2021292397A1 | Chimeric Rsv And Coronavirus Proteins, Immunogenic Compositions, And Methods Of Use |
| AR122651A1 | Rsv And Coronavirus Chimeric Proteins, Immunogenic Compositions, And Methods Of Use |
| TW202208399A | Chimeric Rsv And Coronavirus Proteins, Immunogenic Compositions, And Methods Of Use |
| CA3187161A1 | Chimeric Rsv And Coronavirus Proteins, Immunogenic Compositions, And Methods Of Use |
| WO2021257841A9 | Chimeric Rsv And Coronavirus Proteins, Immunogenic Compositions, And Methods Of Use |
What are Meissa Vaccines key innovation segments?
What Technologies are Covered by Meissa Vaccines?
The chart below distributes patents filed by Meissa Vaccines